Ischemic Not Yet Recruiting Phase 4 Trials for Rosuvastatin (DB01098)

IndicationStatusPhase
DBCOND0056577 (Ischemic)Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02643784Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic StrokeTreatment